Markets
CNC

MEDNAX (MD) in Focus: Stock Moves 13.4% Higher

A generic image of a chart
Credit: Shutterstock photo

MEDNAX, Inc . MD was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $41.35 -$46.32 in the past one-month time frame, witnessed a sharp increase yesterday.

The company's shares rose after Elliott Management, a big hedge fund, revealed a 7% stake in the company and said that it seeks to enhance shareholders' value.

The company has seen two positive versus three negative estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also moved downward, suggesting some trouble down the road. So make sure to keep a close watch on this firm in the near future to see if this recent move higher can last.

MEDNAX currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Mednax, Inc Price and Consensus

Mednax, Inc Price and Consensus | Mednax, Inc Quote

A better-ranked stock in the Medical sector is Centene Corp CNC , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .

Is MD going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Centene Corporation (CNC): Free Stock Analysis Report

Mednax, Inc (MD): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CNC MD

Other Topics

Investing Stocks